In-Gyu Lee
Directeur/Membre du Conseil chez NOVMETAPHARMA CO., LTD.
Profil
In-Gyu Lee is currently a Director at NovMetaPharma Co., Ltd.
and NovMetaHealth Co. Ltd.
He is also a Professor at Kyungpook National University, a position he has held since 2005.
He received his undergraduate, graduate, and doctorate degrees from Kyungpook National University.
Postes actifs de In-Gyu Lee
| Sociétés | Poste | Début |
|---|---|---|
| NOVMETAPHARMA CO., LTD. | Directeur/Membre du Conseil | 13/12/2017 |
| Kyungpook National University | Corporate Officer/Principal | 01/04/2005 |
NovMetaHealth Co. Ltd.
 NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Directeur/Membre du Conseil | - |
Formation de In-Gyu Lee
| Kyungpook National University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVMETAPHARMA CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
